MedPath

A clinical trial to study the effectiveness of three mouth rinses, red ginseng herbal mouthrinse, chlorhexidine, and saline in oral cancer patients

Phase 4
Conditions
Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynxHealth Condition 2: K137- Other and unspecified lesions of oral mucosa
Registration Number
CTRI/2023/09/057325
Lead Sponsor
Dr Nadeem Jeddy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients who were histopathologically diagnosed with oral squamous cell carcinoma and over Stage 2 of TNM classification for oral cancer were included in this study. Patients were above the age of 40 years and included both males and females with any of the tobacco habits. All the patients were treated with modified radical neck dissection surgery followed by radiotherapy.

Exclusion Criteria

Pregnant or lactating women, patients with any systemic disease/in the comorbid condition/on radiotherapy or chemotherapy, patients taking immunosuppressive agents or using systemic corticosteroids, antiresorptive drugs, anti-inflammatory drugs, or antibiotics, patients using any other mouthrinse, patients with a history of allergies, human immunodeficiency virus (HIV), metabolic and bone tissue disorders were excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oral Hygiene Index, Gingival Index, Total Bacterial colony count, & specific bacterial count for Porphyromonas gingivalis & Fusobacterium nucleatum.Timepoint: Baseline & fourteenth day
Secondary Outcome Measures
NameTimeMethod
The outcomes measured include gingival inflammation, improvement in oral hygiene, reduction in the bacterial count, & any symptoms such as a burning sensation while using the mouthrinse.Timepoint: Baseline & fourteenth day
© Copyright 2025. All Rights Reserved by MedPath